Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA PROCTER & GAMBLE HEALTH ORCHID PHARMA/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 41.8 34.5 121.2% View Chart
P/BV x 7.7 10.5 73.2% View Chart
Dividend Yield % 0.0 2.0 -  

Financials

 ORCHID PHARMA   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-23
PROCTER & GAMBLE HEALTH
Jun-23
ORCHID PHARMA/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs4395,366 8.2%   
Low Rs2733,883 7.0%   
Sales per share (Unadj.) Rs163.1740.7 22.0%  
Earnings per share (Unadj.) Rs13.5138.2 9.8%  
Cash flow per share (Unadj.) Rs27.0155.2 17.4%  
Dividends per share (Unadj.) Rs095.00 0.0%  
Avg Dividend yield %02.1 0.0%  
Book value per share (Unadj.) Rs168.7447.6 37.7%  
Shares outstanding (eoy) m40.8216.60 245.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.26.2 34.9%   
Avg P/E ratio x26.333.5 78.6%  
P/CF ratio (eoy) x13.229.8 44.3%  
Price / Book Value ratio x2.110.3 20.4%  
Dividend payout %068.7 0.0%   
Avg Mkt Cap Rs m14,52276,761 18.9%   
No. of employees `000NANA-   
Total wages/salary Rs m6542,062 31.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,65912,296 54.2%  
Other income Rs m194184 105.7%   
Total revenues Rs m6,85312,480 54.9%   
Gross profit Rs m1,2353,247 38.0%  
Depreciation Rs m548281 195.0%   
Interest Rs m3298 4,273.0%   
Profit before tax Rs m5523,142 17.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0847 0.0%   
Profit after tax Rs m5522,295 24.1%  
Gross profit margin %18.526.4 70.2%  
Effective tax rate %027.0 0.0%   
Net profit margin %8.318.7 44.5%  
BALANCE SHEET DATA
Current assets Rs m5,01011,713 42.8%   
Current liabilities Rs m3,7196,791 54.8%   
Net working cap to sales %19.440.0 48.4%  
Current ratio x1.31.7 78.1%  
Inventory Days Days57263 21.8%  
Debtors Days Days1,180343 343.4%  
Net fixed assets Rs m7,24210,617 68.2%   
Share capital Rs m408166 245.9%   
"Free" reserves Rs m6,4787,265 89.2%   
Net worth Rs m6,8867,431 92.7%   
Long term debt Rs m1,4880-   
Total assets Rs m12,25222,330 54.9%  
Interest coverage x2.7409.1 0.7%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.50.6 98.7%   
Return on assets %7.210.3 69.8%  
Return on equity %8.030.9 26.0%  
Return on capital %10.542.4 24.8%  
Exports to sales %81.90-   
Imports to sales %37.613.1 287.7%   
Exports (fob) Rs m5,452NA-   
Imports (cif) Rs m2,5011,605 155.8%   
Fx inflow Rs m5,4521,465 372.1%   
Fx outflow Rs m2,7261,605 169.8%   
Net fx Rs m2,726-140 -1,944.2%   
CASH FLOW
From Operations Rs m1832,360 7.8%  
From Investments Rs m-312-215 145.2%  
From Financial Activity Rs m312-985 -31.7%  
Net Cashflow Rs m1831,160 15.8%  

Share Holding

Indian Promoters % 69.8 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 18.6 20.3 92.0%  
FIIs % 4.1 7.6 54.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.2 48.2 62.6%  
Shareholders   36,931 56,730 65.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Orchid Pharma vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Orchid Pharma vs Procter & Gamble Health Share Price Performance

Period Orchid Pharma Procter & Gamble Health S&P BSE HEALTHCARE
1-Day -0.40% -0.55% 1.18%
1-Month -14.06% -7.47% -0.75%
1-Year 173.54% -3.02% 61.82%
3-Year CAGR -23.64% -9.12% 18.16%
5-Year CAGR 184.58% 5.75% 19.79%

* Compound Annual Growth Rate

Here are more details on the Orchid Pharma share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of Orchid Pharma hold a 69.8% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Orchid Pharma and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, Orchid Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.

You may visit here to review the dividend history of Orchid Pharma, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.